BioSpace News Archive

Business

Reata Pharmaceuticals, Inc. Announces Third Quarter 2020 Financial Results and Provides an Update on Business Operations and Clinical Development Programs

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced financial results for the quarter ended September 30, 2020, and provided an update on the Company’s business operations and clinical development programs.

November 9, 2020
·
23 min read
Biotech Bay

Nurix Therapeutics to Present at Upcoming Investor Conferences

Nurix Therapeutics, Inc., a biopharmaceutical company developing targeted protein modulation drugs, announced that it will be presenting at the following healthcare investor conferences

November 9, 2020
·
1 min read
Biotech Bay

Codexis to Participate at Three Virtual Investment Conferences in November 2020

Codexis, Inc., a leading protein engineering company, announces that management will participate at three upcoming virtual investment conferences

November 9, 2020
·
1 min read
Business

Morphic Announces Corporate Highlights and Third Quarter 2020 Financial Results

Initiated p hase 1 clinical trial for MORF-057 with results expected by mid-2021 Presented d ata at UEG 2020 that reinforce preclinical potency and selectivity profile of MORF-057 Received $20 million from AbbVie exercising option to αvβ6 integrin inhibitor program

November 9, 2020
·
8 min read
Biotech Bay

IGM Biosciences to Present at Three Upcoming Investor Conferences - Nov 09, 2020

IGM Biosciences, Inc., a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, announced that Fred Schwarzer, Chief Executive Officer, will present at three upcoming investor conferences:

November 9, 2020
·
1 min read
Business

Intercept Pharmaceuticals Reports Third Quarter 2020 Financial Results, Announces Updates to Financial Guidance and Provides Business Update

Worldwide Ocaliva net sales of $79.5 million in the third quarter 2020, representing 29% growth over the prior year quarter

November 9, 2020
·
24 min read
Business

Neos Therapeutics Reports Third Quarter 2020 Financial Results

Neos Therapeutics, Inc., a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, reported financial results for the third quarter ended September 30, 2020 and provided a business update.

November 9, 2020
·
9 min read
Business

Zentalis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Update

Announced topline data from thePhase 1 monotherapy dose escalation trial of ZN-c5, its investigational oral SERD, in patients with ER+/HER2- advanced breast cancer; Phase 2 trial expected to initiate in H1 2021

November 9, 2020
·
10 min read
Drug Development

Applied Therapeutics Announces Presentation of Pre-Clinical Data on AT-001 for the Treatment of Diabetic Cardiomyopathy at the American Heart Association (AHA) Scientific Sessions 2020

Treatment with AT-001 normalizes cardiac energetics and improves cardiac function in a mouse model of Diabetic Cardiomyopathy (DbCM)

November 9, 2020
·
3 min read
Business

Recro Reports Third Quarter 2020 Financial Results

Company Secures Three-Year Renewal of License and Supply Agreement with Lannett, A Generics Pharmaceutical Company, for Manufacturing of Verelan PM®, Verelan SR® and Verapamil PM

November 9, 2020
·
17 min read